Great crowd today for Nanoscope Therapeutics CMO Dr. Samuel Barone's presentation at Ophthalmology Futures Forum in Barcelona where he talked about our optogenetic #genetherapy pipelines for #retinitispigmentosa, #stargardt and #GA #off2024 #euretina2024 #retina

Today at EURETINA Congress. Don't miss our Symposium to learn more about groundbreaking optogenetic therapies for retinal disease. #retinitispigmentosa #genetherapy #euretina2024

Friday in Barcelona at #Euretina2024. Prof. Jordi Mones presenting topline results from our Phase 2b/3 #ClinicalTrials of MCO-010 for #Retinitispigmentosa. Join us!

On #WorldSightDay2024 Nanoscope Therapeutics announces plans to submit BLA for MCO-010 to treat #Retinitispigmentosa in Q12025. #stargardt #genetherapy #ophthalmology #clinicaltrials #blindness .Details: bit.ly/3Y28I3P

Nanoscope Therapeutics leadership will be presenting at #AAO2024 later this week in Chicago. Presentations will update on MCO-010 for #RP, #Stargardts, #GA For full details: bit.ly/4f4u0of

ICYMI: At 52 weeks posttreatment, patients treated in the high dose cohort showed a mean improvement of 0.337 ± 0.0829 LogMAR in comparison to the sham-control group (P = .0209). #RetinitisPigmentosa #Ophthalmology #AAO2024 Nanoscope Therapeutics Read more: cgtlive.com/view/nanoscope…

Welcome Sunil Gupta, MD to the Nanoscope Therapeutics Inc. Board of Directors. Dr. Gupta is a nationally recognized retinal surgeon and a successful entrepreneur who brings deep experience in all phases of drug development and medical devices. bit.ly/3YFkQrH

Excited that Dr. Mohapatra will present today at the Vitreo-Retinal Society-India Annual Conference. If you are there, do not miss his talk! #retinitispigmentosa #clinicaltrials #retina

Welcome Ray Kaczmarek to Nanoscope Therapeutics .

We are excited welcome Ramesh Arjunji, PhD, to the Nanoscope team. Details: bit.ly/4h8FbwX

Welcome to Nanoscope Dr. Daramola! #optogenetics #ophthalmology #genetherapy #retinitispigmentosa #stargardt Details at nanostherapeutics.com

Nanoscope Therapeutics welcomes Ashish Patel, PhD as SVP, Sales&Marketing. Full details bit.ly/3FGKfeW #genetherapy #ophthalmology #biotechnology

Congratulations to Dr. Subrata Batabyal, or Director, Nonclinical Developement! We celebrate your accomplishments. Details: bit.ly/4jWkJ47

Nanoscope Therapeutics in New Orleans this week for #ASGCT2025! We are excited to present groundbreaking research on our MCO-010 - vision restoring #genetherapy for #RP and #Stargardt. Details bit.ly/45amFSr #ophthalmology #restorevision

Exciting news at Nanoscope Therapeutics! Excited to welcome #retina leaders to our new Visionary Advisory Committee. Read more: bit.ly/40jXycv#ophtha… #genetherapy

We are proud to announce the initiation of a rolling submission of a BLA to the US FDA for our lead investigational therapy, MCO-010, for the treatment of severe vision loss due to #retinitispigmentosa #RP bit.ly/4nO7PYD #fightblindness

.Nanoscope Therapeutics noted that the first modules of MCO-010's BLA have been submitted to the agency and that full submission is expected to be finished early next year. #genetherapy #RetinitisPigmentosa #Ophthalmology More: hubs.li/Q03xpmwp0

A new peer-reviewed paper has been published highlighting groundbreaking research that supports our lead asset therapy, MCO-010, and its potential to help restore vision in people living with retinal degenerative diseases. bit.ly/3IH0DgX #RP #fightblindness

Excited to attend #ASRS2025 in Long Beach! See you there. ASRS tp://bit.ly/3TX3dSx #retinitispigmentosa #ophthalmology #retina #rp Nanoscope Therapeutics

Proud to share important global regulatory updates for our lead disease-agnostic optogenetic therapy, MCO-010: Read the full PR: bit.ly/3Vs3NIv #retina #ophthalmology #Retinitispigmentosa #stargardt